EcoDrugPlus

Lysine Demethylase 1a

Ensembl ID : ENSOMEG00000015181
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSOMEG00000007284
Gene Symbol: LOC112139968
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSOMEG00000003519
Gene Symbol: LOXL2
3 Cross references
210 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSOMEG00000021665
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSOMEG00000002108
Gene Symbol: LOC112145561
2 Cross references
188 Possible Orthologues:

Mast Cell Protease 8-Like

Ensembl ID : ENSOMEG00000015087
Gene Symbol: LOC112137028
3 Cross references
969 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSOMEG00000001620
Gene Symbol: MMP1
4 Cross references
283 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSOMEG00000015721
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSOMEG00000020574
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSOMEG00000012965
Gene Symbol: LOC112147164
3 Cross references
196 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSOMEG00000014869
Gene Symbol: LOC112156455
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSOMEG00000006185
Gene Symbol: LOC112149602
2 Cross references
163 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).